|
|
Prepublished online as a Blood First Edition Paper on June 7, 2002; DOI 10.1182/blood-2001-12-0291.
Previous Article | Table of Contents | Next Article 
Blood, 1 October 2002, Vol. 100, No. 7, pp. 2562-2571
IMMUNOBIOLOGY
Role for granulocyte colony-stimulating factor in the
generation of human T regulatory type 1 cells
Sergio Rutella,
Luca Pierelli,
Giuseppina Bonanno,
Simona Sica,
Franco Ameglio,
Ettore Capoluongo,
Andrea Mariotti,
Giovanni Scambia,
Giuseppe d'Onofrio, and
Giuseppe Leone
From the Departments of Hematology and Gynecology,
Catholic University Medical School, Rome, and the Laboratory of
Clinical Pathology and Microbiology, IRCCS San Gallicano, Rome, Italy.
Granulocyte colony-stimulating factor (G-CSF) may affect
T-cell homeostasis by multiple mechanisms, inducing polarization of
cytokine secretion, inhibition of T-cell proliferation, and enhancement
of T-cell apoptosis. We analyzed the production of interleukin-10
(IL-10) and transforming growth factor- 1 (TGF- 1) by T cells from
healthy volunteer donors treated with recombinant human G-CSF. Highly
purified CD4+ T cells obtained before and after G-CSF
administration (pre-G and post-G, respectively) were activated
using the allogeneic mixed leukocyte reaction. Post-G CD4+
T cells produced high levels of IL-10 but undetectable levels of IL-2
and IL-4, whereas the level of TGF- 1 release was comparable to that
of pre-G CD4+ T cells. Notably, post-G CD4+ T
cells proliferated poorly in response to alloantigens and to recall
antigens and suppressed the proliferation of autologous CD4+ T cells in a cell contact-independent and an
antigen-nonspecific manner. TGF- 1 and IL-10 were not dispensable
for post-G CD4+ T cells to mediate suppression, as shown by
neutralization studies. Compared with pre-G CD4+ T cells,
alloantigen-activated post-G CD4+ T cells preferentially
expressed markers associated with memory T cells, in conjunction with
reduced levels of CD28 and CD62L. Collectively, these data demonstrate
that CD4+ T cells exposed to G-CSF in vivo acquire the
properties of T regulatory (Tr) cells once triggered in vitro through
the T-cell receptor, including a peculiar cytokine production profile
(IL-10++TGF- 1+IL-2low/ IL-4low/ ),
an intrinsic low proliferative capacity, and a contact-independent suppression of antigen-driven proliferation. Tr cells generated ex vivo
after exposure to G-CSF might be clinically relevant for transplantation medicine and for the treatment of human
immune-mediated diseases.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Collazo, D. Wood, K. H. T. Paraiso, E. Lund, R. W. Engelman, C.-T. Le, D. Stauch, K. Kotsch, and W. G. Kerr
SHIP limits immunoregulatory capacity in the T-cell compartment
Blood,
March 26, 2009;
113(13):
2934 - 2944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Guerin, J. R. Prins, and S. A. Robertson
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
Hum. Reprod. Update,
March 11, 2009;
(2009)
dmp004v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. C. Baumeister, K. Holig, M. Bornhauser, M. Meurer, E. P. Rieber, and K. Schakel
G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity
Blood,
October 15, 2007;
110(8):
3078 - 3081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, S. Danese, and G. Leone
Tolerogenic dendritic cells: cytokine modulation comes of age
Blood,
September 1, 2006;
108(5):
1435 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Rezvani, S. Mielke, M. Ahmadzadeh, Y. Kilical, B. N. Savani, J. Zeilah, K. Keyvanfar, A. Montero, N. Hensel, R. Kurlander, et al.
High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT
Blood,
August 15, 2006;
108(4):
1291 - 1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, G. Bonanno, A. Procoli, A. Mariotti, D. G. de Ritis, A. Curti, S. Danese, G. Pessina, S. Pandolfi, F. Natoni, et al.
Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features
Blood,
July 1, 2006;
108(1):
218 - 227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Condomines, P. Quittet, Z.-Y. Lu, L. Nadal, P. Latry, E. Lopez, M. Baudard, G. Requirand, C. Duperray, J.-F. Schved, et al.
Functional Regulatory T Cells Are Collected in Stem Cell Autografts by Mobilization with High-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor.
J. Immunol.,
June 1, 2006;
176(11):
6631 - 6639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Morris, K. P. A. MacDonald, and G. R. Hill
Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
Blood,
May 1, 2006;
107(9):
3430 - 3435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, F. Zavala, S. Danese, H. Kared, and G. Leone
Granulocyte Colony-Stimulating Factor: A Novel Mediator of T Cell Tolerance
J. Immunol.,
December 1, 2005;
175(11):
7085 - 7091.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Banovic, K. P. A. MacDonald, E. S. Morris, V. Rowe, R. Kuns, A. Don, J. Kelly, S. Ledbetter, A. D. Clouston, and G. R. Hill
TGF-{beta} in allogeneic stem cell transplantation: friend or foe?
Blood,
September 15, 2005;
106(6):
2206 - 2214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Leone, S. Rutella, G. Bonanno, A. Abbate, A. G. Rebuzzi, S. Giovannini, M. Lombardi, L. Galiuto, G. Liuzzo, F. Andreotti, et al.
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function
Eur. Heart J.,
June 2, 2005;
26(12):
1196 - 1204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Dudley, J. R. Wunderlich, J. C. Yang, R. M. Sherry, S. L. Topalian, N. P. Restifo, R. E. Royal, U. Kammula, D. E. White, S. A. Mavroukakis, et al.
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma
J. Clin. Oncol.,
April 1, 2005;
23(10):
2346 - 2357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. A. MacDonald, V. Rowe, A. D. Clouston, J. K. Welply, R. D. Kuns, J. L. M. Ferrara, R. Thomas, and G. R. Hill
Cytokine Expanded Myeloid Precursors Function as Regulatory Antigen-Presenting Cells and Promote Tolerance through IL-10-Producing Regulatory T Cells
J. Immunol.,
February 15, 2005;
174(4):
1841 - 1850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kared, A. Masson, H. Adle-Biassette, J.-F. Bach, L. Chatenoud, and F. Zavala
Treatment With Granulocyte Colony-Stimulating Factor Prevents Diabetes in NOD Mice by Recruiting Plasmacytoid Dendritic Cells and Functional CD4+CD25+ Regulatory T-Cells
Diabetes,
January 1, 2005;
54(1):
78 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Morris, K. P. A. MacDonald, V. Rowe, D. H. Johnson, T. Banovic, A. D. Clouston, and G. R. Hill
Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplantation tolerance
Blood,
May 1, 2004;
103(9):
3573 - 3581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Yamagami, S. Yokoo, T. Mimura, and S. Amano
Effects of TGF-{beta}2 on Immune Response-Related Gene Expression Profiles in the Human Corneal Endothelium
Invest. Ophthalmol. Vis. Sci.,
February 1, 2004;
45(2):
515 - 521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rutella, G. Bonanno, M. Marone, D. de Ritis, A. Mariotti, M. T. Voso, G. Scambia, S. Mancuso, G. Leone, and L. Pierelli
Identification of a Novel Subpopulation of Human Cord Blood CD34-CD133-CD7-CD45+Lineage- Cells Capable of Lymphoid/NK Cell Differentiation After In Vitro Exposure to IL-15
J. Immunol.,
September 15, 2003;
171(6):
2977 - 2988.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|